Abstract:Since the discovery of antibiotics, penicillin has remained the top choice in clinical medicine. With continuous advancements in biotechnology, penicillin production has become cost-effective and efficient. Genetic engineering techniques have been employed to enhance biosynthetic pathways, leading to the production of new penicillin derivatives with improved properties and increased efficacy against antibiotic-resistant pathogens. Advances in bioreactor design, media formulation, and process optimization have contributed to higher yields, reduced production costs, and increased penicillin accessibility. While biotechnological advances have clearly benefited the global production of this life-saving drug, they have also created challenges in terms of waste management. Production fermentation broths from industries contain residual antibiotics, by-products, and other contaminants that pose direct environmental threats, while increased global consumption intensifies the risk of antimicrobial resistance in both the environment and living organisms. The current geographical and spatial distribution of antibiotic and penicillin consumption dramatically reveals a worldwide threat. These challenges are being addressed through the development of novel waste management techniques. Efforts are aimed at both upstream and downstream processing of antibiotic and penicillin production to minimize costs and improve yield efficiency while lowering the overall environmental impact. Yield optimization using artificial intelligence (AI), along with biological and chemical treatment of waste, is also being explored to reduce adverse impacts. The implementation of strict regulatory frameworks and guidelines is also essential to ensure proper management and disposal of penicillin production waste. This review is novel because it explores the key remaining challenges in antibiotic development, the scope of machine learning tools such as Quantitative Structure-Activity Relationship (QSAR) in modern biotechnology-driven production, improved waste management for antibiotics, discovering alternative path to reducing antibiotic use in agriculture through alternative meat production, addressing current practices, and offering effective recommendations.

New Progress In Enzymatic Semi-Synthesis Of Beta-Lactam Antibiotics

Research Progress in Chemical Semi-synthetic Modification of Thiopeptide Antibiotics

Harnessing biocatalysis as a green tool in antibiotic synthesis and discovery

Progress in Enzymatic Synthesis of Drug Derivatives

The polymer-supported and combinatorial synthesis of beta-lactam compounds: an update

Semisynthesis: An Essential Tool for Antibiotics Drug Discovery

Harnessing biotechnology for penicillin production: Opportunities and environmental considerations

Biosynthetic process and strain improvement approaches for industrial penicillin production

Combining Biological and Chemical Approaches for Green Synthesis of Chemicals

Enzymatic Polymerization: a Green Technique for Polymer Synthesis

Biotechnological advances on penicillin G acylase: pharmaceutical implications, unique expression mechanism and production strategies

Progress in Synthesis of Thiopeptide Antibiotics Analogues

Toward steadfast growth of antibiotic research in China: from natural products to engineered biosynthesis.

Efficient Synthesis of Highly Enantiopure Β-Lactam Derivatives from Biocatalytic Transformations of Amides and Nitriles

Biocatalysis for Green Chemistry and Drug Development

Recent Advances in Synthetic Biology Approaches to Optimize Production of Bioactive Natural Products in Actinobacteria

Biocatalysis for the Synthesis of Active Pharmaceutical Ingredients in Deep Eutectic Solvents: State-of-the-Art and Prospects

Biocatalysis in Development of Green Pharmaceutical Processes.

Application of modern biotechnology in antibiotic production

Advances in enzymatic reaction of penicillin acylase in non-aqueous media

Cell-free Synthetic Biology in the New Era of Enzyme Engineering